ArticleFrontiers in oncology2021

Development and Validation of a Nomogram for Predicting Prognosis to Immune Checkpoint Inhibitors Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer.

Hao Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.